A new research has shed light on why some cancer cells don't respond to chemotherapy, and identified a mechanism to rectify that. The research is from Western University.
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to.
Chemotherapy
''Chemo'' means medicine or ''drug'', ''therapy'' means ''treatment''. Chemotherapy refers to the use of cytotoxic drugs in the treatment of cancer.
Advertisement
Dr. Shawn Li, PhD, and his team at Western's Schulich School of Medicine and Dentistry, identified that a protein called Numb functions to promote the death of cancer cells by binding to and stabilizing a tumor suppressor protein called p53 -a master regulator of cell death.
The scientists found when Numb is reduced or methylated by an enzyme called Set8, it will no longer protect p53.
"If you don't have Numb in a cell, then the p53 can be degraded very quickly, and these cells become resistant to chemotherapy," explained Li, a professor of Biochemistry and Canada Research Chair in Cellular Proteomics and Functional Genomics.
![Chemotherapy Drugs]( "Chemotherapy Drugs")
Chemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body.
"So if we can prevent Numb from being methylated in cancer cells, then we will have the means to sensitize the cell to chemotherapy," he explained.
Now that he's identified the Set8-Numb-p53 pathway, Li is investigating various drugs to find a Set8 inhibitor, which could be used as a novel breast cancer therapy alone, or in combination with other chemotherapy regiments.
The research has been published in the latest issue of Molecular Cell.
Source: ANI
"If you don't have Numb in a cell, then the p53 can be degraded very quickly, and these cells become resistant to chemotherapy," explained Li, a professor of Biochemistry and Canada Research Chair in Cellular Proteomics and Functional Genomics.
Chemotherapy Drugs
Chemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body.
Advertisement
"So if we can prevent Numb from being methylated in cancer cells, then we will have the means to sensitize the cell to chemotherapy," he explained.
Now that he's identified the Set8-Numb-p53 pathway, Li is investigating various drugs to find a Set8 inhibitor, which could be used as a novel breast cancer therapy alone, or in combination with other chemotherapy regiments.
The research has been published in the latest issue of Molecular Cell.
Source: ANI
Toxoplasmosis
Brief overview of a common disease called Toxoplasmosis and its risks in human population
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
